BIOMAT Database Logo BIOMAT Database Logo

Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial. 1988

J P Galmiche, and G Brandstätter, and M Evreux, and E Hentschel, and E Kerstan, and P Kratochvil, and W Reichel, and K Schütze, and J C Soule, and J Vitaux
Clinique des maladies de l'appareil digestif, Hôpital Guillaume et René Laennec, Nantes, France.

Combined treatment with cimetidine 1 g daily and cisapride 40 mg daily in patients with endoscopically diagnosed severe reflux oesophagitis was compared with single drug therapy (cimetidine and placebo). At the end of the six to 12 weeks treatment, 11 (46%) of the 24 patients under single drug therapy were endoscopically healed and three were improved. In contrast, 16 (70%) of the 23 patients under combined therapy were healed and all of the remainder were improved (p = 0.025). The severity of diurnal and nocturnal heartburn, decreased significantly more (p less than 0.05) on cimetidine + cisapride than on cimetidine + placebo. The combined treatment was well tolerated. These results suggest that combined therapy with cisapride and cimetidine may be useful in patients with severe reflux oesophagitis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010880 Piperidines A family of hexahydropyridines.
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004942 Esophagitis, Peptic INFLAMMATION of the ESOPHAGUS that is caused by the reflux of GASTRIC JUICE with contents of the STOMACH and DUODENUM. Esophagitis, Reflux,Esophagitides, Peptic,Esophagitides, Reflux,Peptic Esophagitides,Peptic Esophagitis,Reflux Esophagitides,Reflux Esophagitis
D004945 Esophagoscopy Endoscopic examination, therapy or surgery of the esophagus. Esophagoscopic Surgical Procedures,Surgical Procedures, Esophagoscopic,Esophagoscopic Surgery,Surgery, Esophagoscopic,Esophagoscopic Surgeries,Esophagoscopic Surgical Procedure,Esophagoscopies,Procedure, Esophagoscopic Surgical,Procedures, Esophagoscopic Surgical,Surgeries, Esophagoscopic,Surgical Procedure, Esophagoscopic

Related Publications

J P Galmiche, and G Brandstätter, and M Evreux, and E Hentschel, and E Kerstan, and P Kratochvil, and W Reichel, and K Schütze, and J C Soule, and J Vitaux
Cimetidine plus cisapride for reflux oesophagitis.
July 1988, Lancet (London, England),
J P Galmiche, and G Brandstätter, and M Evreux, and E Hentschel, and E Kerstan, and P Kratochvil, and W Reichel, and K Schütze, and J C Soule, and J Vitaux
Maintenance therapy with cisapride after healing of erosive oesophagitis: a double-blind placebo-controlled trial.
June 1997, Alimentary pharmacology & therapeutics,
J P Galmiche, and G Brandstätter, and M Evreux, and E Hentschel, and E Kerstan, and P Kratochvil, and W Reichel, and K Schütze, and J C Soule, and J Vitaux
Oral cimetidine in reflux esophagitis: a double blind controlled trial.
May 1978, Gastroenterology,
J P Galmiche, and G Brandstätter, and M Evreux, and E Hentschel, and E Kerstan, and P Kratochvil, and W Reichel, and K Schütze, and J C Soule, and J Vitaux
Sucralfate versus cimetidine in reflux oesophagitis. A double-blind clinical study.
February 1991, Scandinavian journal of gastroenterology,
J P Galmiche, and G Brandstätter, and M Evreux, and E Hentschel, and E Kerstan, and P Kratochvil, and W Reichel, and K Schütze, and J C Soule, and J Vitaux
Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial.
January 1988, Annales chirurgiae et gynaecologiae,
J P Galmiche, and G Brandstätter, and M Evreux, and E Hentschel, and E Kerstan, and P Kratochvil, and W Reichel, and K Schütze, and J C Soule, and J Vitaux
Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis.
May 1990, Digestive diseases and sciences,
J P Galmiche, and G Brandstätter, and M Evreux, and E Hentschel, and E Kerstan, and P Kratochvil, and W Reichel, and K Schütze, and J C Soule, and J Vitaux
Oral cimetidine in severe duodenal ulceration. A double-blind controlled trial.
January 1977, Lancet (London, England),
J P Galmiche, and G Brandstätter, and M Evreux, and E Hentschel, and E Kerstan, and P Kratochvil, and W Reichel, and K Schütze, and J C Soule, and J Vitaux
Treatment of reflux oesophagitis with a carbenoxolone/antacid/alginate preparation. A double-blind controlled trial.
November 1986, Scandinavian journal of gastroenterology,
J P Galmiche, and G Brandstätter, and M Evreux, and E Hentschel, and E Kerstan, and P Kratochvil, and W Reichel, and K Schütze, and J C Soule, and J Vitaux
Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study.
January 1984, Digestion,
J P Galmiche, and G Brandstätter, and M Evreux, and E Hentschel, and E Kerstan, and P Kratochvil, and W Reichel, and K Schütze, and J C Soule, and J Vitaux
Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.
February 1978, Gastroenterology,
Copied contents to your clipboard!